Right Turn Show- Exploring Dapagliflozin Beyond Glycemic Benefits Deeksha Bhandari8 April 2025 12:34 PM ISTIn the last episode, we explored the role of Dapagliflozin in specialty care settings. Moving forward, this episode delves into Dapagliflozin Beyond...
USV Launches Empagliflozin Range Under Xenia Brand Deeksha Bhandari2 April 2025 12:23 PM ISTUSV Pvt. Ltd., a leader in diabetes care, has announced the launch of its Xenia brand range in India, following the patent expiry of Empagliflozin. ...
Lupin Launches Ajaduo M Forte, a Triple Fixed-Dose Combination of Empagliflozin, Linagliptin, and Metformin Extended Release (ER) MDTV Bureau31 March 2025 10:15 AM ISTGlobal pharmaceutical company Lupin Limited has announced the launch of Ajaduo M Forte, a novel triple fixed-dose combination (FDC) therapy for the...
REFORM study: Reviewing Effects of Vildagliptin-Dapagliflozin FDC on HbA1c & Weight in Type 2 Diabetes Management MD Brand Connect17 Jan 2025 12:00 PM ISTThe fixed-dose combination (FDC) of Vildagliptin 100mg SR and Dapagliflozin 10mg showed significant glycemic control, weight reduction, and favorable...
Right Turn Show - Decoding the Use of Dapagliflozin and its Combinations with Metformin and Sitagliptin in Specialty Care Settings MD Brand Connect18 Dec 2024 12:00 PM ISTPresenting Episode 2 of the Right Turn Show, in this episode, insights from leading experts are explored on the practical application of dapagliflozin...
Right Turn Show - Optimal Use of Dapagliflozin and its Combinations in Specialty Care Settings MD Brand Connect30 Oct 2024 10:00 AM ISTBringing you the 'Right Turn Show,' where we focus on the optimal use of dapagliflozin and its combinations in speciality care settings. In this...
Glipizide in T2DM Care - Latest Update from ADA 2024 MD Brand Connect9 July 2024 12:08 PM ISTThe 84th Scientific Sessions of the American Diabetes Association, held in Orlando, Florida, from June 21 to June 24, 2024, featured significant...
Insights from "EVER-Vilda", Expert Perspective on Vildagliptin's Applicability in Indian T2DM Patients MDTV Bureau14 March 2024 2:45 AM ISTThe "EVER-Vilda" opinion paper is an Indian expert's evaluation of the efficacy and rationality of vildagliptin. It underscores vildagliptin's...
Lupin Launches Dapaturn GM Range for Improved Approach to Manage Type 2 Diabetes MD Brand Connect1 Jan 2024 11:45 AM ISTGlobal pharma major Lupin Limited announced the launch of Dapaturn GM Forte for the treatment of diabetic patients in India. Lupin's Dapaturn GMâ„¢...
USV Launches Liralin Range for Diverse Group of Type 2 Diabetes Patients MD Brand Connect4 Sept 2023 1:55 PM ISTUSV Pvt. Ltd, a leading drug manufacturer in the diabetes & cardiology segment, has announced the launch of the Liralin Range for the treatment...
